What Is Tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. By co-activating both GIP and GLP-1 signaling pathways, Tirzepatide delivers potent glucose regulation, enhanced postprandial insulin secretion, and significant central satiety signaling superior to single GLP-1 receptor agonists like Semaglutide. Researchers exploring metabolic pathways also study triple agonists such as Retatrutide alongside Tirzepatide.
Tirzepatide possesses a C20 fatty diacid diacid moiety attached via a linker that enables non-covalent binding to human serum albumin, extending its pharmacokinetic half-life to approximately 5 days (120 hours). Precise dosage arithmetic using our peptide calculator is vital, as research protocols require incremental dose titration from 2.5 mg up to 15.0 mg weekly using sterile bacteriostatic water.
Tirzepatide possesses a C20 fatty diacid diacid moiety attached via a linker that enables non-covalent binding to human serum albumin, extending its pharmacokinetic half-life to approximately 5 days (120 hours). Precise dosage arithmetic using our peptide calculator is vital, as research protocols require incremental dose titration from 2.5 mg up to 15.0 mg weekly using sterile bacteriostatic water.
Tirzepatide Dosage Chart
Tirzepatide research protocols involve step-wise dose escalations every 4 weeks. Reconstitution volumes must be selected based on the total vial mass to maintain manageable volumetric draw units. A 2.0 mL reconstitution volume for 10 mg or 15 mg vials provides an optimal balance between volumetric accuracy and small injection volume.
Vial: 5 mgWater: 1.0 mL
Concentration5.0 mg/mL
Target Dose2.5 mg (2,500 mcg)
Draw to Mark:50.0 Units
Vial: 10 mgWater: 2.0 mL
Concentration5.0 mg/mL
Target Dose2.5 mg (2,500 mcg)
Draw to Mark:50.0 Units
Vial: 10 mgWater: 2.0 mL
Concentration5.0 mg/mL
Target Dose5.0 mg (5,000 mcg)
Draw to Mark:100.0 Units
Vial: 15 mgWater: 3.0 mL
Concentration5.0 mg/mL
Target Dose7.5 mg (7,500 mcg)
Draw to Mark:150.0 Units (1.5 mL)
Vial: 30 mgWater: 3.0 mL
Concentration10.0 mg/mL
Target Dose5.0 mg (5,000 mcg)
Draw to Mark:50.0 Units
| Vial Size | Bac Water Added | Concentration | Target Research Dose | Draw Units (U-100) |
|---|---|---|---|---|
| 5 mg | 1.0 mL | 5.0 mg/mL | 2.5 mg (2,500 mcg) | 50.0 Units |
| 10 mg | 2.0 mL | 5.0 mg/mL | 2.5 mg (2,500 mcg) | 50.0 Units |
| 10 mg | 2.0 mL | 5.0 mg/mL | 5.0 mg (5,000 mcg) | 100.0 Units |
| 15 mg | 3.0 mL | 5.0 mg/mL | 7.5 mg (7,500 mcg) | 150.0 Units (1.5 mL) |
| 30 mg | 3.0 mL | 10.0 mg/mL | 5.0 mg (5,000 mcg) | 50.0 Units |
How to Reconstitute Tirzepatide
Dissolving lyophilized Tirzepatide requires care to avoid damaging the fatty-acid acylated peptide backbone. Following laboratory Standard Operating Procedures ensures long-term solution stability and sterile integrity.
Syringe Reading Diagram
U-100 Syringe Graduation & Measurement Line (Tirzepatide)
5 Standard Reconstitution Steps for Tirzepatide
- Disinfect the rubber stoppers of both the Tirzepatide vial and bacteriostatic water vial using 70% isopropyl alcohol wipes. Allow 10 seconds to air dry.
- Using a sterile reconstitution syringe, draw the exact amount of bacteriostatic water desired (e.g. 2.0 mL).
- Incline the Tirzepatide vial and insert the needle, directing the stream down the internal glass wall. Do not inject diluent directly into the powder cake.
- Swirl the vial in a slow circular motion between your hands. Allow the vial to stand for 5 to 10 minutes until all particles complete dissolution.
- Verify that the resulting liquid is completely transparent and free of particulate matter before refrigerating at 2°C–8°C.
❄️ Storage & Shelf-Life Notice (Tirzepatide)
Once reconstituted with Bacteriostatic Water containing 0.9% benzyl alcohol, Tirzepatide solutions maintain potency for up to 30 days under refrigeration (2°C–8°C). Protect vials from direct ultraviolet light exposure.
⚠️ Common Preparation Mistakes to Avoid
Common errors include using plain sterile water for injection instead of bacteriostatic water (leading to bacterial proliferation in multi-dose vials) and vigorous shaking that creates persistent micro-bubbles and protein aggregation.
Tirzepatide Dosing FAQ
How much bac water do I add to 10mg Tirzepatide?↓
Adding 2.0 mL of bacteriostatic water to a 10 mg Tirzepatide vial yields a concentration of 5 mg/mL. At this concentration, 2.5 mg equals 50 units (0.5 mL) on a U-100 syringe.
How do I draw a 2.5 mg dose from a 5mg Tirzepatide vial?↓
Reconstitute the 5 mg vial with 1.0 mL of bac water (5 mg/mL concentration). Draw 50 units (0.5 mL) on your U-100 syringe to get a 2.5 mg dose.
What is the half-life of Tirzepatide?↓
Tirzepatide has an elimination half-life of approximately 5 days (120 hours), supporting steady plasma drug levels with once-weekly administration.
Why does Tirzepatide require gradual escalation?↓
In research studies, starting at 2.5 mg and titrating upward every 4 weeks allows GI tract adaptation to GIP/GLP-1 receptor activation, minimizing adverse nausea.
Can Tirzepatide be combined with Cagrilintide?↓
Dual research protocols exploring Tirzepatide with Cagrilintide investigate complementary amylin and GIP/GLP-1 agonism for augmented metabolic study.
Related Peptide Calculators & Stacks
Cagrilintide
Calculate Cagrilintide amylin analogue reconstitution, milligram dosing, and U-100 syringe units.
Calculate Cagrilintide→
Retatrutide
Calculate Retatrutide triple-agonist reconstitution, dosing units, and U-100 syringe draw math.
Calculate Retatrutide→
Semaglutide
Calculate Semaglutide GLP-1 agonist reconstitution, dosing conversion, and U-100 syringe units.
Calculate Semaglutide→